Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Asthma | R-HSA-444620 | map05310 | aminophenazone | 54766 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | aminophenazone | 54766 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | aminophenazone | 54766 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | aminophenazone | 54766 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | aminophenazone | 54766 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | aminophenazone | 54766 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | aminophenazone | 54766 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | aminophenazone | 54766 | drug-path |
Hedgehog signaling pathway | R-HSA-5358351 | map04340 | aminophenazone | 54766 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | aminophenazone | 54766 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | levobunolol | 39468 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | levobunolol | 39468 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | levobunolol | 39468 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | levobunolol | 39468 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | levobunolol | 39468 | drug-path |
Asthma | R-HSA-444620 | map05310 | levobunolol | 39468 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | levobunolol | 39468 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | levobunolol | 39468 | drug-path |
Shigellosis | 0 | map05131 | levobunolol | 39468 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | levobunolol | 39468 | drug-path |